153 related articles for article (PubMed ID: 16283107)
1. Gamma interferon: a central mediator in atherosclerosis.
Leon ML; Zuckerman SH
Inflamm Res; 2005 Oct; 54(10):395-411. PubMed ID: 16283107
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?
Harvey EJ; Ramji DP
Cardiovasc Res; 2005 Jul; 67(1):11-20. PubMed ID: 15907820
[TBL] [Abstract][Full Text] [Related]
3. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
McLaren JE; Michael DR; Ashlin TG; Ramji DP
Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
[TBL] [Abstract][Full Text] [Related]
4. Interferon gamma: a master regulator of atherosclerosis.
McLaren JE; Ramji DP
Cytokine Growth Factor Rev; 2009 Apr; 20(2):125-35. PubMed ID: 19041276
[TBL] [Abstract][Full Text] [Related]
5. Adaptive immunity and atherosclerosis.
Andersson J; Libby P; Hansson GK
Clin Immunol; 2010 Jan; 134(1):33-46. PubMed ID: 19635683
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice.
Koga M; Kai H; Yasukawa H; Yamamoto T; Kawai Y; Kato S; Kusaba K; Kai M; Egashira K; Kataoka Y; Imaizumi T
Circ Res; 2007 Aug; 101(4):348-56. PubMed ID: 17495225
[TBL] [Abstract][Full Text] [Related]
7. Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis.
Harvey EJ; Li N; Ramji DP
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):806-12. PubMed ID: 17255531
[TBL] [Abstract][Full Text] [Related]
8. Collagens in the progression and complications of atherosclerosis.
Adiguzel E; Ahmad PJ; Franco C; Bendeck MP
Vasc Med; 2009 Feb; 14(1):73-89. PubMed ID: 19144782
[TBL] [Abstract][Full Text] [Related]
9. KLF4: a novel target for the treatment of atherosclerosis.
Yan FF; Liu YF; Liu Y; Zhao YX
Med Hypotheses; 2008; 70(4):845-7. PubMed ID: 17869009
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ in foam cell formation and progression of atherosclerosis.
Yu XH; Zhang J; Zheng XL; Yang YH; Tang CK
Clin Chim Acta; 2015 Feb; 441():33-43. PubMed ID: 25512166
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis and interferon-γ: new insights and therapeutic targets.
Voloshyna I; Littlefield MJ; Reiss AB
Trends Cardiovasc Med; 2014 Jan; 24(1):45-51. PubMed ID: 23916809
[TBL] [Abstract][Full Text] [Related]
12. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
13. Site-specific atherogenic gene expression correlates with subsequent variable lesion development in coronary and peripheral vasculature.
Mohler ER; Sarov-Blat L; Shi Y; Hamamdzic D; Zalewski A; Macphee C; Llano R; Pelchovitz D; Mainigi SK; Osman H; Hallman T; Steplewski K; Gertz Z; Lu MM; Wilensky RL
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):850-5. PubMed ID: 18276914
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation.
Wilensky RL; Hamamdzic D
Curr Opin Cardiol; 2007 Nov; 22(6):545-51. PubMed ID: 17921743
[TBL] [Abstract][Full Text] [Related]
15. Adventitial lymphatic vessels -- an important role in atherosclerosis.
Xu X; Lin H; Lv H; Zhang M; Zhang Y
Med Hypotheses; 2007; 69(6):1238-41. PubMed ID: 17825501
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity, macrophage activation, and atherosclerosis.
Yan ZQ; Hansson GK
Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
[TBL] [Abstract][Full Text] [Related]
17. Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells.
Martín-Ventura JL; Madrigal-Matute J; Muñoz-Garcia B; Blanco-Colio LM; Van Oostrom M; Zalba G; Fortuño A; Gomez-Guerrero C; Ortega L; Ortiz A; Diez J; Egido J
Cardiovasc Res; 2009 Aug; 83(3):586-94. PubMed ID: 19423618
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in atherosclerosis: pathogenic and regulatory pathways.
Tedgui A; Mallat Z
Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells in atherosclerosis: functions in immune regulation and beyond.
Manthey HD; Zernecke A
Thromb Haemost; 2011 Nov; 106(5):772-8. PubMed ID: 21901235
[TBL] [Abstract][Full Text] [Related]
20. Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages.
Abe M; Matsuda M; Kobayashi H; Miyata Y; Nakayama Y; Komuro R; Fukuhara A; Shimomura I
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):871-7. PubMed ID: 18323514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
